Intratio
Quantitative Research
Skip to main content
AI Market Summary
Loading market intelligence...
  • Sign in
    My account
    Logout
AI 90-DAY FORECAST
BEARISH SIGNAL DETECTED
██.█% Sign up free to reveal

Ss Innovations International, Inc. (SSII) AI Forecast

Our AI detected a significant signal for Ss Innovations International, Inc.. Create a free account to see the exact price target.

✓ Free account • ✓ 30-day free trial

$SSII Bearish Signal Full forecast available
Sign Up Free

Ss Innovations International, Inc. (SSII) Stock Forecast 2025

Ss Innovations International, Inc. (SSII) AI Stock Price Forecast & Investment Analysis

Ss Innovations International, Inc. Stock Price Chart and Technical Analysis

Loading chart...

Ss Innovations International, Inc. (SSII) - Comprehensive Stock Analysis & Investment Research

Deep dive into Ss Innovations International, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Analysis updated on April 22, 2026, 5:24 a.m. (UTC)

Ss Innovations International, Inc. Investment Summary

When evaluating whether Ss Innovations International, Inc. (SSII) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.

Company Profile

Ss Innovations International, Inc. (SSII) operates within the Industrial Applications and Services sector, specifically in the Surgical & Medical Instruments & Apparatus industry. . With a market capitalization of $949 million, the company is a small-cap stock that may offer higher growth potential but also carries higher volatility.

Financial Performance Analysis

Our comprehensive financial analysis covers Ss Innovations International, Inc.'s revenue, profitability metrics, balance sheet strength, and cash flow generation...

AI Price Predictions

Get AI-powered 7-day, 30-day and 90-day price forecasts for Ss Innovations International, Inc. along with confidence scores and detailed analysis...

Investment Considerations

Expert analysis of whether Ss Innovations International, Inc. is suitable for your investment objectives, risk tolerance, and time horizon...

Continue Reading Full Analysis

Get the complete investment breakdown for Ss Innovations International, Inc.

Sign Up Free
Corporate Identity

Ss Innovations International, Inc. (Stock Symbol: SSII) is a prominent company operating within the Industrial Applications and Services sector, with a specific focus on the Surgical & Medical Instruments & Apparatus industry. The company's shares are publicly traded on the Nasdaq exchange.

Leadership & Workforce

Detailed information about Ss Innovations International, Inc.'s leadership team, workforce size, and organizational structure...

Market Classification

Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Ss Innovations International, Inc....

Sector & Industry Analysis

In-depth sector dynamics and industry context for Ss Innovations International, Inc....

Unlock Full Company Profile

Get complete details about Ss Innovations International, Inc.

Sign Up Free
Revenue & Growth Analysis

Ss Innovations International, Inc. generates annual revenues of $42 million , representing an emerging company in its growth phase.

Profitability Metrics

Net profit margin, gross margin, and operating margin analysis for Ss Innovations International, Inc....

Market Valuation

P/E ratio, price-to-book, and valuation multiples for Ss Innovations International, Inc....

Return Metrics

Return on equity (ROE), return on assets (ROA), and capital efficiency for Ss Innovations International, Inc....

Unlock Financial Analysis

Get complete financial metrics for Ss Innovations International, Inc.

Sign Up Free
AI ANALYSIS AVAILABLE

Unlock Ss Innovations International, Inc.'s AI Price Forecast

Join 10,000+ investors using our 67%+ accurate AI predictions

4,000+ Stocks Analyzed
67%+ Accuracy Rate
Daily Updates
Start 30-Day Free Trial →

✓ 30-day free trial • ✓ Cancel anytime

Strategic Market Position

Ss Innovations International, Inc. strategically competes in the highly dynamic Surgical & Medical Instruments & Apparatus marketplace. As a small-cap company, it represents an emerging market participant with potentially significant growth opportunities. Small-caps often offer greater growth potential as they capture market share and scale their operations, though this comes with higher risk and volatility. Success at this stage can lead to substantial returns for early investors who identify winning business models.

Industry Competitive Landscape

Ss Innovations International, Inc. competes within the Industrial Applications and Services sector, navigating the competitive dynamics and market forces specific to this industry. The company's competitive position depends on its ability to differentiate through product quality, cost efficiency, customer relationships, or other strategic advantages relevant to its specific market segment.

Operational Efficiency

The company currently shows negative free cash flow of $-22 million . Negative free cash flow may reflect heavy investment in growth, working capital needs, or operational challenges. This is common for high-growth companies investing aggressively but warrants attention for mature businesses.

Asset Utilization Efficiency

Asset turnover ratio of 0.57x indicates moderate asset turnover common in capital-intensive industries such as utilities, real estate, or heavy manufacturing. Lower turnover in these sectors is expected due to the significant infrastructure required for operations.

Financial Strength & Leverage

Ss Innovations International, Inc. (SSII) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Ss Innovations International, Inc. stock analysis.

Deep dive into Ss Innovations International, Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Ss Innovations International, Inc. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Ss Innovations International, Inc.:

P/B Ratio 24.83x
Market Cap $949M
Book Value/Share $0.19
Revenue/Share $0.21
FCF/Share $-0.11
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Ss Innovations International, Inc. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Ss Innovations International, Inc.: An ROE of -4.0% indicates room for improvement in shareholder value creation.

ROE -4.0%
ROA -2.1%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Ss Innovations International, Inc.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Ss Innovations International, Inc.:

D/E Ratio 0.94x
Financial Leverage 1.94x
Interest Coverage 2.2x
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Ss Innovations International, Inc.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Ss Innovations International, Inc.: Free cash flow of $-22M indicates cash challenges that need attention.

Operating Cash Flow -$910K
Free Cash Flow -$22M
Capital Spending -$21M
FCF/Sales -52.3%
CapEx/Sales 50.1%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Ss Innovations International, Inc. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Ss Innovations International, Inc.: An asset turnover of 0.57x suggests room for improvement in asset utilization.

Asset Turnover 0.57x
Understanding Financial Statement Data

What these metrics mean: Key figures from Ss Innovations International, Inc.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Ss Innovations International, Inc.: With annual revenue of $42M, Ss Innovations International, Inc. represents a smaller but potentially high-growth operation.

Income Statement
Total Revenue $42M
Net Income -$1M
R&D Expense $200K
Balance Sheet Highlights (% Of Assets)
Total Liabilities 36%
Dividend & Shareholder Information
Shares Outstanding 200M

Latest Ss Innovations International, Inc. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Ss Innovations International, Inc. (SSII) stock price and investment outlook.

More news available

Sign up free to read all 9 news articles and stay updated on market developments.

Sign Up Free to Read More

Ss Innovations International, Inc. Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of Ss Innovations International, Inc. against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
Adagio Medical Holdings, Inc. ADGM ██% $32M x 2.6x
Aethlon Medical Inc AEMD ██% $4M x 0.6x
Acutus Medical, Inc. AFIB ██% $0.00M 0.0x -0.4x
Allurion Technologies, Inc. ALUR ██% $12M x x
Autonomix Medical, Inc. AMIX ██% $4M x 0.5x
Angiodynamics Inc ANGO ██% $447M x 2.6x
Anika Therapeutics, Inc. ANIK ██% $209M x 1.5x
Artivion, Inc. AORT ██% $1.66B 169.7x 3.7x
Apyx Medical Corp APYX ██% $163M x 11.2x
Accuray Inc ARAY ██% $50M 4.9x 0.8x
Alphatec Holdings, Inc. ATEC ██% $1.57B x 126.7x
Atricure, Inc. ATRC ██% $1.36B x 2.8x
Nuo Therapeutics, Inc. AURX ██% $71M x x
Avita Medical, Inc. AVHHL ██% $22M x x
Baxter International Inc BAX ██% $9.49B x 1.6x
Beta Bionics, Inc. BBNX ██% $547M x 2.0x
Becton Dickinson & Co BDX ██% $56.77B 32.3x 2.3x
Heartbeam, Inc. BEAT ██% $46M x 17.6x
Bluejay Diagnostics, Inc. BJDX ██% $2M x 0.3x
Boston Scientific Corp BSX ██% $88.11B 30.4x 3.6x
Biotricity Inc. BTCY ██% $7M x x
Bioventus Inc. BVS ██% $642M 28.3x 3.5x
Brainsway Ltd. BWAY ██% $615M x x
Carlsmed, Inc. CARL ██% $286M x 2.9x
Cerus Corp CERS ██% $371M x 5.8x
Clearpoint Neuro, Inc. CLPT ██% $315M x 11.2x
Co-Diagnostics, Inc. CODX ██% $6M x 0.3x
Cytosorbents Corp CTSO ██% $39M x 6.6x
Cvrx, Inc. CVRX ██% $200M x 5.1x
Delcath Systems, Inc. DCTH ██% $370M 137.0x 3.3x
Dih Holding Us, Inc. DHAI ██% $70K x -0.3x
Dariohealth Corp. DRIO ██% $50M x 0.7x
Alpha Tau Medical Ltd. DRTS ██% $695M x 9.0x
Dexcom Inc DXCM ██% $24.09B 28.8x 8.8x
Dynatronics Corp DYNT ██% $540K -0.2x 0.2x
Dynatronics Corp DYNTQ ██% $130K x 0.0x
Ebr Systems, Inc. EBRCZ ██% $270M x 10.6x
Encision Inc ECIA ██% $3M x 1.8x
Embecta Corp. EMBC ██% $541M 3.9x x
Electromedical Technologies, Inc EMED ██% $750K x x
Femasys Inc FEMY ██% $25M x 4.2x
Family Office Of America, Inc. FOFA ██% $30M x 37.9x
Glucotrack, Inc. GCTK ██% $1M x 0.5x
Global Innovative Platforms Inc. GIPL ██% $320K x 2.0x
Glaukos Corp GKOS ██% $7.02B x 10.7x
Globus Medical Inc GMED ██% $12.69B 23.6x 2.8x
Fractyl Health, Inc. GUTS ██% $88M x 9.3x
Haemonetics Corp HAE ██% $2.82B 16.1x 3.1x
Harvard Apparatus Regenerative Technology, Inc. HRGN ██% $26M x 25.0x
Heartflow, Inc. HTFL ██% $2.74B x 9.1x
Integra Lifesciences Holdings Corp IART ██% $856M x 0.8x
Icecure Medical Ltd. ICCM ██% $29M x 3.3x
Seastar Medical Holding Corp ICU ██% $88M -1.1x 7.7x
Icu Medical Inc/De ICUI ██% $3.22B 4404.0x 1.5x
Interpace Biosciences, Inc. IDXG ██% $60M 2.4x 2.7x
Inspira Technologies Oxy B.H.N. Ltd IINN ██% $26M x 11.0x
Inspira Technologies Oxy B.H.N. Ltd IINNW ██% $7M x 1.5x
Intelligent Bio Solutions Inc. INBS ██% $6M x 0.5x
Infusystem Holdings, Inc INFU ██% $169M 30.5x 3.0x
Inspire Medical Systems, Inc. INSP ██% $1.63B 11.2x 2.1x
Iradimed Corp IRMD ██% $1.19B 52.8x 12.6x
Irhythm Holdings, Inc. IRTC ██% $4.03B x 26.4x
Invo Fertility, Inc. IVF ██% $16M x 2.7x
Orthopediatrics Corp KIDS ██% $418M x 1.2x
Kestra Medical Technologies, Ltd. KMTS ██% $1.36B x 4.7x
Koru Medical Systems, Inc. KRMD ██% $198M x 11.6x
Lemaitre Vascular Inc LMAT ██% $2.62B 45.4x 6.7x
Lensar, Inc. LNSR ██% $67M x x
Lucid Diagnostics Inc. LUCD ██% $221M x 20.3x
Pulmonx Corp LUNG ██% $59M x 1.1x
Lyra Therapeutics, Inc. LYRA ██% $1M x x
Microbot Medical Inc. MBOT ██% $154M x 2.0x
Mountain Crest Acquisition Corp. V MCAG ██% N/A x x
Mountain Crest Acquisition Corp. V MCAGU ██% $31M x -9.9x
Spectral Ai, Inc. MDAI ██% $58M x x
Medinotec Inc. MDNC ██% $59M 25.1x 10.7x
Mimedx Group, Inc. MDXG ██% $481M 9.9x 1.9x
Monogram Technologies Inc. MGRM ██% $217M -10.7x 25.1x
Meihua International Medical Technologies Co., Ltd. MHUA ██% $151M x 0.9x
3m Co MMM ██% $80.28B 24.7x 17.1x
Merit Medical Systems Inc MMSI ██% $4.15B 32.3x 2.6x
Modular Medical, Inc. MODD ██% $25M x 4.3x
Nephros Inc NEPH ██% $33M 27.4x 3.2x
Neuroone Medical Technologies Corp NMTC ██% $42M x 6.6x
Neuropace Inc NPCE ██% $555M x 29.2x
Inspiremd, Inc. NSPR ██% $59M x 1.1x
Nu-Med Plus, Inc. NUMD ██% $1M x x
Novocure Ltd NVCR ██% $1.43B x 4.2x
Envveno Medical Corp NVNO ██% $8M x 0.3x
Nexgel, Inc. NXGL ██% $5M x 1.2x
Nyxoah Sa NYXH ██% $139M x x
Orchestra Biomed Holdings, Inc. OBIO ██% $248M x 4.6x
Odyssey Health, Inc. ODYY ██% $7M x x
Orthofix Medical Inc. OFIX ██% $504M x 1.1x
Osr Holdings, Inc. OSRH ██% $20M x 0.3x
Orasure Technologies Inc OSUR ██% $225M x 0.7x
Pavmed Inc. PAVM ██% $60M 148.7x 1.8x
Pro Dex Inc PDEX ██% $171M 15.1x 4.1x
Penumbra Inc PEN ██% $12.93B 72.8x 9.1x
Petvivo Holdings, Inc. PETV ██% $28M x 8.2x
Profusa, Inc. PFSA ██% $3M x x
Polyrizon Ltd. PLRZ ██% $19M x 0.9x
Pulse Biosciences, Inc. PLSE ██% $1.61B x 20.0x
Picard Medical, Inc. PMI ██% $66M x 17.5x
Insulet Corp PODD ██% $14.14B 57.2x 9.3x
Procept Biorobotics Corp PRCT ██% $1.45B x 4.0x
Premier Air Charter Holdings Inc. PREM ██% $2M x 2.6x
Profound Medical Corp. PROF ██% $260M x 3.9x
Plus Therapeutics, Inc. PSTV ██% $50M x 12.5x
Polypid Ltd. PYPD ██% $85M x 7.8x
Avita Medical, Inc. RCEL ██% $153M x x
Vivos Inc RDGL ██% $32M x 19.2x
Resmed Inc RMD ██% $32.94B 22.2x 5.2x
Resmed Inc RSMDF ██% $3.82B 2.7x 0.6x
Retinalgenix Technologies Inc. RTGN ██% N/A x x
Retractable Technologies Inc RVP ██% $19M x 0.3x
Sight Sciences, Inc. SGHT ██% $233M x 3.7x
Si-Bone, Inc. SIBN ██% $625M x 3.5x
Sigyn Therapeutics, Inc. SIGY ██% $60K x x
Sintx Technologies, Inc. SINT ██% $11M x 3.8x
Beauty Health Co SKIN ██% $113M x 1.8x
Sonoma Pharmaceuticals, Inc. SNOA ██% $5M x 1.3x
Sanuwave Health, Inc. SNWV ██% $175M 14.8x 108.2x
Solventum Corp SOLV ██% $12.32B 7.9x 2.4x
Sensus Healthcare, Inc. SRTS ██% $68M x 1.4x
Ss Innovations International, Inc. SSII ██% $949M x 24.8x
Strata Skin Sciences, Inc. SSKN ██% $1M x 0.3x
Neuronetics, Inc. STIM ██% $109M x 4.9x
Stimcell Energetics Inc. STME ██% $7M x x
Sharps Technology Inc. STSS ██% $72M x 0.3x
Stevanato Group S.P.A. STVN ██% $4.34B x x
Stryker Corp SYK ██% $129.22B 39.8x 5.8x
Tactile Systems Technology Inc TCMD ██% $572M 30.0x 2.6x
Tela Bio, Inc. TELA ██% $28M x 4.4x
Teleflex Inc TFX ██% $5.75B x 1.8x
Trisalus Life Sciences, Inc. TLSI ██% $283M x x
Trisalus Life Sciences, Inc. TLSIW ██% $62M x -1.9x
Treace Medical Concepts, Inc. TMCI ██% $126M x 1.4x
Tandem Diabetes Care Inc TNDM ██% $1.43B x 9.2x
Tenon Medical, Inc. TNON ██% $9M x 1.7x
T2 Biosystems, Inc. TTOO ██% $210K 0.0x -0.3x
Ufp Technologies Inc UFPT ██% $1.53B 22.5x 3.6x
Qhslab, Inc. USAQ ██% $9M 19.7x 5.6x
Utah Medical Products Inc UTMD ██% $224M 19.8x 1.9x
Venus Concept Inc. VERO ██% $580K x 0.2x
Catheter Precision, Inc. VTAK ██% $3M x 0.4x
Vivos Therapeutics, Inc. VVOS ██% $14M x 5.5x
Vycor Medical Inc VYCO ██% $2M x x
West Pharmaceutical Services Inc WST ██% $19.80B 40.1x 6.2x
Beyond Air, Inc. XAIR ██% $6M x 0.7x
Xtant Medical Holdings, Inc. XTNT ██% $75M 15.0x 1.5x
Reveal all forecasts See exact % predictions for all competitors
Sign up free

Frequently Asked Questions - Ss Innovations International, Inc. Stock Forecast

How accurate are Ss Innovations International, Inc. stock predictions?

Our AI model shows a -51% Spearman correlation coefficient for SSII predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Ss Innovations International, Inc. stock price forecasts?

Our analysis considers Ss Innovations International, Inc.'s financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Ss Innovations International, Inc. a good investment in 2025?

Based on our AI analysis, Ss Innovations International, Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Ss Innovations International, Inc. forecasts updated?

Ss Innovations International, Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want a simpler view of Ss Innovations International, Inc.?

View simplified analysis on AI Stock Finder →

My Portfolio

Investment Dashboard

Loading your portfolio...